AU2002232492A1 - Rapidly dispersing pharmaceutical composition comprising effervescent agents - Google Patents

Rapidly dispersing pharmaceutical composition comprising effervescent agents

Info

Publication number
AU2002232492A1
AU2002232492A1 AU2002232492A AU3249202A AU2002232492A1 AU 2002232492 A1 AU2002232492 A1 AU 2002232492A1 AU 2002232492 A AU2002232492 A AU 2002232492A AU 3249202 A AU3249202 A AU 3249202A AU 2002232492 A1 AU2002232492 A1 AU 2002232492A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
effervescent agents
rapidly dispersing
dispersing pharmaceutical
rapidly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232492A
Inventor
Xiaorong He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia LLC
Original Assignee
Pharmacia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia LLC filed Critical Pharmacia LLC
Publication of AU2002232492A1 publication Critical patent/AU2002232492A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
AU2002232492A 2000-12-06 2001-12-05 Rapidly dispersing pharmaceutical composition comprising effervescent agents Abandoned AU2002232492A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25169400P 2000-12-06 2000-12-06
US60/251,694 2000-12-06
PCT/US2001/046645 WO2002045684A2 (en) 2000-12-06 2001-12-05 Rapidly dispersing pharmaceutical composition comprising effervescent agents

Publications (1)

Publication Number Publication Date
AU2002232492A1 true AU2002232492A1 (en) 2002-06-18

Family

ID=22953015

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232492A Abandoned AU2002232492A1 (en) 2000-12-06 2001-12-05 Rapidly dispersing pharmaceutical composition comprising effervescent agents

Country Status (6)

Country Link
US (1) US20030035833A1 (en)
EP (1) EP1345592A2 (en)
JP (1) JP2004514732A (en)
AU (1) AU2002232492A1 (en)
CA (1) CA2436570A1 (en)
WO (1) WO2002045684A2 (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
US7838029B1 (en) 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008500288A (en) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー Oral therapeutic compound delivery system
EP1863466B1 (en) * 2005-03-03 2017-08-09 Takasago International Corporation (USA) Synergistic salivation components
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
FR2902337B1 (en) * 2005-12-02 2010-09-17 Vacher Dominique IMMEDIATELY RELEASED TABLETS AND THEIR PRODUCTION
JP5630998B2 (en) * 2006-05-15 2014-11-26 マサチューセッツ インスティテュート オブ テクノロジー Polymers for functional particles
US20080032907A1 (en) * 2006-08-01 2008-02-07 Bernard Patenaude Shaver head cleanser
SI2526934T1 (en) 2006-09-22 2016-04-29 Pharmacyclics Llc Inhibitors of bruton's tyrosine kinase
US8809273B2 (en) 2007-03-28 2014-08-19 Pharmacyclics, Inc. Inhibitors of Bruton's tyrosine kinase
WO2009048940A2 (en) * 2007-10-08 2009-04-16 Dr. Reddy's Laboratories Ltd. Diacerein pharmaceutical formulations
US20100233272A1 (en) * 2007-11-15 2010-09-16 Leah Elizabeth Appel Dosage forms comprising celecoxib providing both rapid and sustained pain relief
JP5401708B2 (en) 2008-01-18 2014-01-29 高砂香料工業株式会社 Process for producing (2E, 6Z, 8E) -N-isobutyl-2,6,8-decatrienamide (spirantol)
AU2009270856B2 (en) 2008-07-16 2013-07-25 Pharmacyclics Llc Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
ES2758624T3 (en) * 2009-02-12 2020-05-06 Fuji Chem Ind Co Ltd Composition of disintegrating particles and compression molded rapid disintegration material comprising the same
DE102009011928A1 (en) * 2009-03-10 2010-09-23 Licciardi, Natale, Dipl.-Ing. Process for the preparation of cleaning tablets
AP2015008955A0 (en) 2009-04-24 2015-12-31 Icuetica Pty Ltd A novel formulation of indomethacin
WO2010150144A2 (en) 2009-06-25 2010-12-29 Wockhardt Research Centre Low dose pharmaceutical compositions of celecoxib
MX2020011961A (en) 2010-03-24 2022-04-19 Jazz Pharmaceuticals Inc Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances.
JP5925766B2 (en) * 2010-05-04 2016-05-25 ジャズ、ファーマシューティカルズ、インコーポレイテッドＪａｚｚ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． Immediate release formulation and dosage form of γ-hydroxybutyrate
MX342405B (en) 2010-06-03 2016-09-28 Pharmacyclics Inc The use of inhibitors of bruton's tyrosine kinase (btk).
BR112014000653A2 (en) 2011-07-13 2017-02-14 Pharmacyclics Inc bruton tyrosine kinase inhibitors
US8377946B1 (en) 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
KR20150015021A (en) 2012-06-04 2015-02-09 파마시클릭스, 인코포레이티드 Crystalline forms of a bruton's tyrosine kinase inhibitor
AU2013293087B2 (en) 2012-07-24 2017-08-31 Pharmacyclics Llc Mutations associated with resistance to inhibitors of Bruton's tyrosine kinase (BTK)
PE20151495A1 (en) 2012-11-15 2015-10-23 Pharmacyclics Inc PYRROLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS
EP3027192A4 (en) 2013-08-02 2017-03-22 Pharmacyclics, LLC Methods for the treatment of solid tumors
ES2709509T3 (en) 2013-08-12 2019-04-16 Pharmacyclics Llc Procedures for the treatment of cancer amplified by HER2
MA38961A1 (en) 2013-09-30 2018-05-31 Pharmacyclics Llc 3-phenyl-1h-pyrazolo [3,4-d] pyrimidin-4-ylamine compounds substituted for the crude tyrosine kinase inhibitors used to treat, for example, autoimmune, respiratory and inflammatory diseases, cancer, mastocytosis and osteoporosis
EP4115886A1 (en) 2013-10-25 2023-01-11 Pharmacyclics LLC Methods of treating and preventing graft versus host disease
WO2015143400A1 (en) 2014-03-20 2015-09-24 Pharmacyclics, Inc. Phospholipase c gamma 2 and resistance associated mutations
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
CA2959602A1 (en) 2014-08-01 2016-02-04 Pharmacyclics Llc Inhibitors of bruton's tyrosine kinase
WO2016022942A1 (en) 2014-08-07 2016-02-11 Pharmacyclics Llc Novel formulations of a bruton's tyrosine kinase inhibitor
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
RU2017133990A (en) 2015-03-03 2019-04-05 Фармасайкликс Элэлси PHARMACEUTICAL MEDICINAL FORMS OF BRUTON TYROSINKINASE INHIBITOR
CN104721169B (en) * 2015-03-28 2017-09-12 河北仁合益康药业有限公司 A kind of Celebret preparation compositions
US11478427B2 (en) * 2015-10-26 2022-10-25 Aron H. Blaesi Dosage form comprising structural framework of two-dimensional elements
EP3368010A4 (en) * 2015-10-26 2019-04-10 Blaesi, Aron H. Solid dosage form immediate drug release and apparatus and method for manufacture thereof
US11129798B2 (en) 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
UY37341A (en) 2016-07-22 2017-11-30 Flamel Ireland Ltd FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
KR20210094513A (en) 2018-11-19 2021-07-29 재즈 파마슈티칼즈 아일랜드 리미티드 Alcohol-Resistant Drug Formulations
CA3127871A1 (en) 2019-03-01 2020-09-10 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1595220A (en) * 1977-12-23 1981-08-12 Fisons Ltd Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
US4864492A (en) * 1986-09-17 1989-09-05 International Business Machines Corporation System and method for network configuration
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
NZ239802A (en) * 1990-09-21 1993-09-27 Merrell Dow Pharma A superior tasting pharmaceutical composition having porous particles produced through in situ gas generation and a process for its production
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2793685B1 (en) * 1999-05-19 2001-08-24 Promindus Actions Promotionnel PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THEIR PREPARATION
AU2001257400A1 (en) * 2000-04-28 2001-11-12 Internet Security Systems, Inc. System and method for managing security events on a network
AU2001286374A1 (en) * 2001-09-04 2003-03-18 E-Cop.Net Pte Ltd Computer security event management system

Also Published As

Publication number Publication date
EP1345592A2 (en) 2003-09-24
CA2436570A1 (en) 2002-06-13
JP2004514732A (en) 2004-05-20
US20030035833A1 (en) 2003-02-20
WO2002045684A2 (en) 2002-06-13
WO2002045684A3 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
AU2002232492A1 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2001295657A1 (en) Formulation containing wax-esters
AU2001263839A1 (en) Liquid formulations
AU2002258221A1 (en) Medicinal composition
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2002221115A1 (en) Medicinal compositions having improved absorbability
AU2001283344A1 (en) Dermatological formulation
AU2001273919A1 (en) Pharmaceutical compositions
AUPQ634300A0 (en) Synergistic formulations
AU4085201A (en) Pharmaceutical composition
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2879801A (en) Effervescent compositions comprising nimesulide
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001262928A1 (en) Pharmaceutical compositions and their use
AUPR099200A0 (en) New formulation
AU2002354460A1 (en) Medicinal composition
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
GB0014851D0 (en) Novel pharmaceutical formulation
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AU2001282541A1 (en) Medicinal compositions